Point of Sale Voucher Program

The Point of Sale Voucher Program is only available for patients:

  • in this Program prior to December 31, 2016, and
  • who are taking ARNUITY ELLIPTA (fluticasone furoate inhalation powder) or INCRUSE ELLIPTA (umeclidinium inhalation powder)
  • The Point of Sale (POS) voucher program works in real time at participating pharmacies for patients insured through commercial health plans who are subject to certain formulary limitations (such as a prior authorization, step-edit, or NDC block) for certain GSK medications. The program offers eligible patients medications at no cost. This program is not offered for residents of Massachusetts or for patients enrolled in or eligible for Medicare, and patients enrolled in Medicaid, or any similar state or federal program.

    This Program does not constitute health insurance.

    Brands included in this program are:

How does this point of sale voucher program work?

Once the pharmacist submits the prescription, the automated voucher will be applied for eligible patients. There is no need to provide additional information or a paper coupon or free trial offer to the pharmacist.

How long will the program last?

The Point of Sale Voucher Program is no longer available for new patients as of Dec. 31, 2016. The Program will end for all patients on Dec. 31, 2017.

Customer Support:

For questions or more information about this program please click this link to access the GSK Response Center site where you find contact information and submit questions online.